HK1003941A1 - Therapeutic nucleosides - Google Patents

Therapeutic nucleosides

Info

Publication number
HK1003941A1
HK1003941A1 HK98103255A HK98103255A HK1003941A1 HK 1003941 A1 HK1003941 A1 HK 1003941A1 HK 98103255 A HK98103255 A HK 98103255A HK 98103255 A HK98103255 A HK 98103255A HK 1003941 A1 HK1003941 A1 HK 1003941A1
Authority
HK
Hong Kong
Prior art keywords
therapeutic nucleosides
nucleosides
therapeutic
preparation
relates
Prior art date
Application number
HK98103255A
Other languages
English (en)
Inventor
Mary Susan Daluge
Douglas Alan Livingston
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of HK1003941A1 publication Critical patent/HK1003941A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/46—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C229/48—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups and carboxyl groups bound to carbon atoms of the same non-condensed ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/10—Systems containing only non-condensed rings with a five-membered ring the ring being unsaturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK98103255A 1992-02-25 1998-04-17 Therapeutic nucleosides HK1003941A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929204015A GB9204015D0 (en) 1992-02-25 1992-02-25 Therapeutic nucleosides
PCT/GB1993/000378 WO1993017020A2 (en) 1992-02-25 1993-02-24 Therapeutic nucleosides

Publications (1)

Publication Number Publication Date
HK1003941A1 true HK1003941A1 (en) 1998-11-13

Family

ID=10711016

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98103255A HK1003941A1 (en) 1992-02-25 1998-04-17 Therapeutic nucleosides

Country Status (14)

Country Link
US (5) US5641889A (da)
EP (1) EP0628044B1 (da)
JP (1) JP3172533B2 (da)
KR (1) KR100282584B1 (da)
AT (1) ATE245646T1 (da)
AU (2) AU3571093A (da)
CA (1) CA2130755C (da)
DE (1) DE69333109T2 (da)
DK (1) DK0628044T3 (da)
ES (1) ES2203615T3 (da)
GB (1) GB9204015D0 (da)
HK (1) HK1003941A1 (da)
PT (1) PT628044E (da)
WO (1) WO1993017020A2 (da)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5631370A (en) 1988-01-20 1997-05-20 Regents Of The University Of Minnesota Optically-active isomers of dideoxycarbocyclic nucleosides
CA2001401A1 (en) * 1988-10-25 1990-04-25 Claude Piantadosi Quaternary amine containing ether or ester lipid derivatives and therapeutic compositions
GB9204015D0 (en) 1992-02-25 1992-04-08 Wellcome Found Therapeutic nucleosides
EP0702556B1 (en) * 1993-06-10 2002-10-23 Wake Forest University (phospho)lipids for combatting hepatitis b virus infection
ES2103131T3 (es) 1993-06-21 1997-08-16 Merrell Pharma Inc Nuevos agentes de nucleosido carbociclico utiles como inhibidores selectivos de citoquinas proinflamatorias.
EP0630897A3 (en) * 1993-06-25 1995-03-01 Bristol Myers Squibb Co 3-hydroxy-4-hydroxymethyl-2-methylene-cyclopentyl purines and pyrimidines.
WO1995022330A1 (en) * 1994-02-17 1995-08-24 Commonwealth Scientific And Industrial Research Organisation Antiviral agents
US7135584B2 (en) 1995-08-07 2006-11-14 Wake Forest University Lipid analogs for treating viral infections
AU3216695A (en) * 1994-08-29 1996-03-22 University Of North Carolina At Chapel Hill, The Lipid analogs for treating viral infections
ES2229362T3 (es) * 1996-05-30 2005-04-16 Lonza Ag Procedimiento para preparar aminoalcoholes y sus derivados.
US5866702A (en) * 1996-08-02 1999-02-02 Cv Therapeutics, Incorporation Purine inhibitors of cyclin dependent kinase 2
SK284810B6 (sk) * 1997-05-13 2005-12-01 Lonza Ag Spôsob výroby (1S,4R)- alebo (1R,4S)-4-(2-amino-6-chlór-9-H- purín-9-yl)-2-cyklopentén-1-metanolu
SK284596B6 (sk) 1997-11-27 2005-07-01 Lonza Ag Spôsob výroby (1S,4R)- alebo (1R,4S)-4-(2-amino-6-chlór-9-H- purin-9-yl)-2-cyklopentén-1-metanolu alebo jeho solí
US6362225B1 (en) * 1999-01-21 2002-03-26 George Andreakos Target therapies for treating common viral infections
US6514979B1 (en) 1999-03-03 2003-02-04 University Of Maryland Biotechnology Institute Synergistic combinations of guanosine analog reverse transcriptase inhibitors and inosine monophosphate dehydrogenese inhibitors and uses therefor
YU25500A (sh) 1999-05-11 2003-08-29 Pfizer Products Inc. Postupak za sintezu analoga nukleozida
ES2218225T3 (es) * 1999-09-10 2004-11-16 Stichting Rega V.Z.W. Nucleosidos carbociclicos y procedimiento para obtenerlos.
US7026469B2 (en) 2000-10-19 2006-04-11 Wake Forest University School Of Medicine Compositions and methods of double-targeting virus infections and cancer cells
US7038059B2 (en) 2000-10-18 2006-05-02 Kuraray Co., Ltd. Process for preparation of 4-n-substituted amino-2-aza-1-oxabicyclo[3.3.0] oct-2-ene-6-carboxylic acid esters and process for preparation of their intermediates
ATE301123T1 (de) 2001-06-27 2005-08-15 Cyclacel Ltd 2,6,9-substituierte purinderivate und ihre verwendung bei der behandlung proliferativer krankheiten
GB0219052D0 (en) 2002-08-15 2002-09-25 Cyclacel Ltd New puring derivatives
CA2463719A1 (en) 2003-04-05 2004-10-05 F. Hoffmann-La Roche Ag Nucleotide analogs with six membered rings
GB0320738D0 (en) 2003-09-04 2003-10-08 Glaxo Group Ltd Novel process
US7230002B2 (en) 2004-02-03 2007-06-12 Glenmark Pharmaceuticals Ltd. Dipeptidyl peptidase IV inhibitors; processes for their preparation and compositions thereof
WO2005075426A1 (en) * 2004-02-03 2005-08-18 Glenmark Pharmaceuticals Ltd. Novel dipeptidyl peptidase iv inhibitors; processes for their preparation and compositions thereof
US7767686B2 (en) * 2006-03-03 2010-08-03 Covidien Ag Method of using adenosine receptor blockers during tissue ablation
US20070208042A1 (en) 2006-03-03 2007-09-06 Sherwood Services Ag Method of using vasoconstrictive agents during energy-based tissue therapy
EP2540726B1 (en) 2007-08-02 2019-10-09 Millennium Pharmaceuticals, Inc. Intermediates for the synthesis of E1 activity activating enzyme inhibitors
AU2009282571B2 (en) 2008-08-20 2014-12-11 Merck Sharp & Dohme Corp. Ethynyl-substituted pyridine and pyrimidine derivatives and their use in treating viral infections
TWI409265B (zh) 2008-08-20 2013-09-21 Merck Sharp & Dohme 經取代之吡啶及嘧啶衍生物及彼等於治療病毒感染之用途
CA2734488A1 (en) 2008-08-20 2010-02-25 Southern Research Institute Azo-substituted pyridine and pyrimidine derivatives and their use in treating viral infections
JP5619743B2 (ja) 2008-08-20 2014-11-05 メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． エテニル置換ピリジンおよびピリミジン誘導体およびウイルス感染の治療におけるそれらの使用
HUE026849T2 (en) 2010-01-27 2016-08-29 Viiv Healthcare Company Corp Service Company Therapeutic combination containing dolutegravir, abacavir and lamivudine
WO2012139230A1 (en) 2011-04-14 2012-10-18 Phonak Ag Hearing instrument
GB201513601D0 (en) * 2015-07-31 2015-09-16 Univ Liverpool Antiviral compounds
CN106220515A (zh) * 2016-08-12 2016-12-14 郸城巨鑫生物科技有限公司 一种(1r,4s)‑1‑氨基‑4‑羟甲基‑2‑环戊烯盐酸盐的合成方法
WO2018181102A1 (ja) * 2017-03-29 2018-10-04 ヤマサ醤油株式会社 ヌクレオシド誘導体又はその塩、及びそれを含む医薬組成物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60139653A (ja) * 1983-12-27 1985-07-24 Yoshitomi Pharmaceut Ind Ltd シクロペンテン誘導体
US4543255A (en) * 1984-05-10 1985-09-24 Southern Research Institute Carbocyclic analogs of purine 2'-deoxyribofuranosides
EP0219838A3 (en) * 1985-10-22 1988-04-06 Takeda Chemical Industries, Ltd. Carbocyclic purine nucleosides, their production and use
IN164556B (da) * 1986-03-06 1989-04-08 Takeda Chemical Industries Ltd
US4734194A (en) * 1986-03-25 1988-03-29 The Upjohn Company Combined filter and valve mechanism
IN166499B (da) * 1987-02-12 1990-05-19 Takeda Chemical Industries Ltd
GB8815265D0 (en) * 1988-06-27 1988-08-03 Wellcome Found Therapeutic nucleosides
WO1990006671A2 (en) * 1988-12-12 1990-06-28 Palese Peter M Methods and compositions for the prophylaxis and treatment of hepatitis b virus infections
ES2067693T3 (es) * 1989-10-16 1995-04-01 Chiroscience Ltd Azabicicloheptanona quiral y un procedimiento para su preparacion.
MY104575A (en) * 1989-12-22 1994-04-30 The Wellcome Foundation Ltd Therapeutic nucleosides.
CA2053849A1 (en) * 1990-03-06 1991-09-07 David I. Scheer Methods and compositions for the prophylaxis and treatment of cytomegalovirus infections
GB9204015D0 (en) 1992-02-25 1992-04-08 Wellcome Found Therapeutic nucleosides

Also Published As

Publication number Publication date
DE69333109T2 (de) 2004-04-15
KR100282584B1 (ko) 2001-02-15
JPH07504185A (ja) 1995-05-11
AU2489197A (en) 1997-08-28
JP3172533B2 (ja) 2001-06-04
AU3571093A (en) 1993-09-13
DK0628044T3 (da) 2003-11-17
WO1993017020A3 (en) 1994-03-17
US6392085B2 (en) 2002-05-21
US20010008946A1 (en) 2001-07-19
CA2130755A1 (en) 1993-08-26
GB9204015D0 (en) 1992-04-08
WO1993017020A2 (en) 1993-09-02
US5808147A (en) 1998-09-15
ES2203615T3 (es) 2004-04-16
ATE245646T1 (de) 2003-08-15
DE69333109D1 (de) 2003-08-28
CA2130755C (en) 2004-03-30
EP0628044B1 (en) 2003-07-23
EP0628044A1 (en) 1994-12-14
PT628044E (pt) 2003-12-31
US5840990A (en) 1998-11-24
US5641889A (en) 1997-06-24
KR950700298A (ko) 1995-01-16
US5919941A (en) 1999-07-06
AU707075B2 (en) 1999-07-01

Similar Documents

Publication Publication Date Title
GB9204015D0 (en) Therapeutic nucleosides
BR9305907A (pt) Uso de derivados de substituída para tratamento de esclerose múltipla
HK1011998A1 (en) Antiretroviral enantiomeric nucleotide analogs
FI913236A0 (fi) 9-purinylfosfonsyraderivat.
IL112539A (en) Chloropyrimidine intermediates for preparing-2-aminopurine nucleoside analogues and their preparation
AU8110991A (en) Novel carbocyclic analogs of certain nucleosides
ES2149157T3 (es) Nuevo procedimiento para la preparacion de nucleotidos.
AU8372991A (en) Novel carbocyclic adenosine analogs useful as immunosuppressants
HU9301918D0 (en) Compounds with antiviral effect
CA2166692A1 (en) Novel 9-n-bicyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines
GR3031602T3 (en) Novel 2-substituted indane-2-mercaptoacetylamide tricyclic derivatives useful as inhibitors of enkephalinase.
GB9325618D0 (en) New herbicides
TW282449B (da)
HK1009451A1 (en) Process for the synthesis of nucleoside analogues
AR240397A1 (es) Banera para aplicacion de hidromasajes por burbujeo.

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20130223